Importance of apolipoprotein A-I in multiple sclerosis
Jean-Martin Charcot has first described multiple sclerosis (MS) as a disease of the central nervous system (CNS) over a century ago. MS remains incurable today, and treatment options are limited to disease modifying drugs. Over the years, significant advances in understanding disease pathology have...
Saved in:
Main Authors: | Lidia A Gardner (Author), Michael C Levin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2015-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic Dilemma: An Atypical Case of Astrocytoma in a Patient with Relapsing-Remitting Multiple Sclerosis
by: Chantal Kahovec, et al.
Published: (2021) -
Transmembrane voltage potential is an essential cellular parameter for the detection and control of tumor development in a Xenopus model
by: Brook T. Chernet, et al.
Published: (2013) -
Task-oriented exercise effects on walking and corticospinal excitability in multiple sclerosis: protocol for a randomized controlled trial
by: Zahra Moslemi, et al.
Published: (2023) -
Balancing risk and benefit of SARS-CoV-2 vaccines in children
by: Michael Levin, et al.
Published: (2022) -
The Importance of Kinetoterapy in Multiple Sclerosis
by: Florentina Nechita
Published: (2023)